LEADER 01782nam0 2200397 i 450 
001 VAN00131737
005 20240806100834.941
010   $a978-33-19-10526-0
017 70$2N$a9783319105277
100   $a20201110d2015       |0itac50      ba
101   $aeng
102   $aCH
105   $a||||    |||||
200 1 $aClinical Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antimalarials$fTony K.L. Kiang, Kyle John Wilby, Mary H.H. Ensom
210   $aCham$cAdis$d2015
215   $avii, 146 p.$d24 cm
620   $aCH$dCham$3VANL001889
700  1$aKiang$bTony K. L.$3VANV105562$01832065
701  1$aEnsom$bMary H. H.$3VANV105564$01832066
701  1$aWilby$bKyle J.$3VANV105563$01832067
712   $aAdis international <editore>$3VANV109332$4650
790  1$aKiang, T. K. L.$zKiang, Tony K. L.$3VANV252666
790  1$aKiang, T.K.L.$zKiang, Tony K. L.$3VANV252667
790  1$aEnsom, M. H. H.$zEnsom, Mary H. H.$3VANV252664
790  1$aEnsom, M.H.H.$zEnsom, Mary H. H.$3VANV252665
790  1$aWilby, Kyle John$zWilby, Kyle J.$3VANV252661
790  1$aWilby, K. J.$zWilby, Kyle J.$3VANV252662
790  1$aWilby, K.J.$zWilby, Kyle J.$3VANV252663
801   $aIT$bSOL$c20250725$gRICA
856 4 $uhttps://link.springer.com/book/10.1007/978-3-319-10527-7$zE-book ? Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth
899   $aBIBLIOTECA CENTRO DI SERVIZIO SBA$2VAN15
912   $fN
912   $aVAN00131737
950   $aBIBLIOTECA CENTRO DI SERVIZIO SBA$d15CONS      SBA EBOOK 7549                      $e15EB 7549              20201110            
996   $aClinical Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antimalarials$94405785
997   $aUNICAMPANIA